ArticleOne health outlook2026
Revisiting the applicability of minisatellite marker CH1T1M13779 to investigate the genetic diversity of P. vivax in Nuh district, Haryana, India.
Article in One health outlook, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The focal rise of P. vivax cases, while not uncommon, remains a significant challenge in India’s malaria elimination efforts. In 2015, a dramatic surge in P. vivax cases occurred in Primary Health Centre (PHC)- Punhana, Nuh district, Haryana, India. This focal rise was attributed to the development of an irrigation system near Hathangaon village leading to a higher malaria incidence, breeding habitats and vector densities. Using our previously validated minisatellite marker CH1T1M13779, we investigated the genetic diversity of 41 P. vivax infected samples and observed 10 alleles in two villages- Hathangaon and Raipuri, Nuh district, Haryana, India. Following are the key takeaways-a) The minisatellite marker CH1T1M13779 proved effective for genotyping; b) P. vivax preferential infection of children and adolescents making them a vulnerable age group. Despite limitations in sample size and geographic scope, this study underscores the value of using minisatellite markers for cost-effective, large-scale genotyping surveillance to help prevent future outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.